Nathaniel Calloway - 09 Jan 2024 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Director
Signature
/s/ Rebecca Hilt, Attorney-In-Fact for Nathaniel Calloway
Issuer symbol
LFCR
Transactions as of
09 Jan 2024
Net transactions value
$0
Form type
4
Filing time
10 Jan 2024, 19:14:35 UTC
Previous filing
05 Jun 2023
Next filing
02 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFCR Common Stock Options Exercise +5,906 +32% 24,088 09 Jan 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LFCR Restricted Stock Unit Options Exercise $0 -5,906 -100% $0.000000* 0 09 Jan 2024 Common Stock 5,906 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 The restricted stock units vested on January 9, 2024.